Delivery Order HHSN272201300002I-HHSN27200002

Ended Awarded Last action

Contract number
HHSN27200002
Awardee
Awarding agency
Obligated
$2,185,236

Award facts

Opportunity
  • NIAIDDAIDSNIHAI2012138 Solicitation number
Contract value 58% obligated
  • $2,185,236.42 Current, with exercised options
  • $3,780,242.42 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00018 -$10,732
Funding Only Action P00017 -$332
Funding Only Action P00016 $29,383
Funding Only Action P00015 -$10,883
Funding Only Action P00014 $10,732
Funding Only Action P00013 -$23,166
Other Administrative Action P00012 $0
Funding Only Action P00011 -$40,646
Exercise an Option P00010 $322,170
Exercise an Option 9 $314,498
Funding Only Action 8 -$15,931
Other Administrative Action 7 $0
Exercise an Option 6 $307,005
Exercise an Option 5 $299,702
Exercise an Option 4 $146,334
Exercise an Option 3 $292,590
Exercise an Option 2 $285,645
Other Administrative Action 1 $0
Original award Simian vaccine evaluation units $278,866
Show all 19

About this award

Written by GovTribe AI ·

This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $3,780,242.42, is for the provision of Simian Vaccine Evaluation Units, which involves the development of vaccines and other medical countermeasures for infectious diseases. The contract is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) contract for Simian Vaccine Evaluation Units from 2013 to 2020. The contract does not have a set-aside designation. ABL has been awarded numerous federal contracts and grants, particularly from NIH and HHS, to advance the development of medical countermeasures for various infectious diseases and other health conditions.

Quick answers

Who was awarded contract HHSN27200002?

HHSN27200002 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 1, 2013.

How much is contract HHSN27200002 worth?

The government has obligated $2,185,236 on HHSN27200002. Its potential value, with all options, is $3,780,242.

Is contract HHSN27200002 an order under another contract?

Yes. HHSN27200002 is a delivery order under HHSN272201300002I, an indefinite delivery contract, on Simian Vaccine Evaluation Units 2013-2020.

Was contract HHSN27200002 competed?

The extent of competition for HHSN27200002 was full and open competition. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login